News
12 Health Care Stocks Moving In Wednesday's After-Market Session
24 Apr 24
Movers
Amarin Highlights Key Data Providing Mechanistic Insights Into Eicosapentaenoic Acid At ACC.24
8 Apr 24
Biotech, News, General
Amarin Announces Research Evaluating Benefits Of VASCEPA/VAZKEPA To Be Presented At The American College Of Cardiology's Annual Scientific Session & Expo
25 Mar 24
Biotech, News, Events, General
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
29 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why Is Amarin Stock Trading Lower After Q4 Earnings?
29 Feb 24
Biotech, Earnings, News, Guidance, Health Care, Movers, General
Amarin Corp Q4 Adj EPS $0.00 Beats $(0.03) Estimate, Sales $74.71M Beat $63.81M Estimate
29 Feb 24
Earnings, News
Earnings Scheduled For February 29, 2024
29 Feb 24
Earnings
Press releases
Amarin Applauds HealthyWomen's Citizen's Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
24 Apr 24
Press Releases
New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
8 Apr 24
Press Releases
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
6 Apr 24
Press Releases, General
HLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug Plan
6 Feb 24
Small Cap, Press Releases